Skip to main content
main-content

Glycemic control

News

11-05-2018 | Glycemic control | News

Glycemic variability within normal glucose range tied to poor outcomes

Among individuals without diabetes, high variability in glycated hemoglobin levels is associated with an elevated risk for major adverse cardiovascular events and mortality, researchers report.

10-30-2018 | Glycemic control | Highlight | News

Improved oral health could help glycemic control in type 2 diabetes

A year of intensive periodontal treatment is associated with a significant reduction in glycated hemoglobin levels in patients with type 2 diabetes and moderate-to-severe periodontitis, UK researchers report.

10-11-2018 | Glycemic control | EASD 2018 | News

Natural HbA1c variability can obscure treatment effects

A single glycated hemoglobin measurement will not be sufficient to gauge treatment effects or the need for intensification in many type 2 diabetes patients, research shows.

Read more

Opinion

09-12-2018 | Diet | Commentary | Article

Diet–drug interactions: Why two rights can make a wrong

Editorial Board member and Endocrinologist, Sanjay Kalra comments on the issues raised by a clinical case involving sodium glucose cotransporter 2 inhibitor therapy alongside a restrictive diet.

08-29-2018 | Blood glucose monitoring | Editorial | Article

The ambulatory glucose profile: What, why, and how?

Editorial Board member Lori Berard discusses how the ambulatory glucose profile is quietly revolutionizing the analysis of blood glucose and glycemic control for patients and practitioners.

07-24-2018 | Devices and technology | Editorial | Article

The right device at the right time: Optimizing the benefit

Advisory Board member Katharine Barnard scrutinizes the opinion that clinicians should be relying on glycemic outcomes when weighing the decision to prescribe a diabetes device.

In depth

01-15-2018 | Type 1 diabetes | Hot topic review | Article

What do we know about adjunct non-insulin medications in type 1 diabetes?

medwireNews outlines which medications have so far been tested as adjunct treatments for type 1 diabetes and summarizes the key trial data showing their benefits or otherwise.

03-21-2017 | Insulin pumps | Feature | Article

Adolescents: A challenging age group

Professor Moshe Phillip tells medwireNews why he believes the artificial pancreas will be of particular benefit for adolescents and young adults with type 1 diabetes.

Original research

08-05-2016 | Glycemic control | Article

Stress and coping predicts adjustment and glycemic control in adolescents with type 1 diabetes

Jaser SS et al. Ann Behav Med 2017; 51: 30–38. doi: 10.1007/s12160-016-9825-5

Journal articles and book chapters

09-13-2018 | Pathophysiology | Review | Article

Altered gut microbiota in type 2 diabetes: Just a coincidence?

Sircana A et al. Curr Diab Rep 2018; 18: 98. doi: 10.1007/s11892-018-1057-6

09-07-2018 | Pregnancy | Review | Article

Optimal obstetric management for women with diabetes: The benefits and costs of fetal surveillance

Emeruwa UN, Zera C. Curr Diab Rep 2018; 18: 96. doi: 10.1007/s11892-018-1058-5

09-05-2018 | Older adults | Review | Article

Diabetes treatment in the elderly: Incorporating geriatrics, technology, and functional medicine

Valencia WM et al. Curr Diab Rep 2018; 18: 95. doi: 10.1007/s11892-018-1052-y

In practice

06-01-2017 | Type 2 diabetes | Review | Article

Practical recommendations for transitioning patients with type 2 diabetes from hospital to home

Donihi AC. Curr Diab Rep 2017; 17: 52. doi: 10.1007/s11892-017-0876-1

Case reports

05-28-2018 | Lifestyle interventions | Case report | Article

Successful management of poorly controlled type 2 diabetes with multidisciplinary neurobehavioral rehabilitation: A case report and review

Deng Z et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0448-7

05-10-2018 | Insulin pumps | Case report | Article

Glucose control during kidney transplantation in type 1 diabetes patient on sensor augmented pump: A case report

Zivkovic M, Petrovski G, Bitoska I. Acta Diabetol 2018; Advance online publication. doi: 10.1007/s00592-018-1147-6

01-15-2018 | Prader-Willi syndrome | Case report | Article

Effectiveness of sodium-glucose cotransporter-2 inhibitor as an add-on drug to GLP-1 receptor agonists for glycemic control of a patient with Prader–Willi syndrome: A case report

Horikawa Y et al. Diabetes Ther 2018; 9: 421. doi: 10.1007/s13300-018-0369-5

image credits